Advertisement

The effect of anti-inflammatory agents and inflammation on granulocyte adherence

Evidence for regulation by plasma factors
  • Rob Roy MacGregor
    Correspondence
    Requests for reprints should be addressed to Dr. R. R. MacGregor, 552 Johnson Pavilion, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19174.
    Footnotes
    Affiliations
    Philadelphia, Pennsylvania USA
    Search for articles by this author
  • Author Footnotes
    1 From the Infectious Disease Section, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19174.
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Significant inhibition of granulocyte adherence to nylon fiber columns followed the administration of alcohol, aspirin, sodium salicylate, acetaminophen, indomethacin, phenylbutazone, colchicine or prednisone to normal subjects. The addition of salicylates and glucocorticoids to blood in vitro had no effect on adherence, but plasma from volunteer subjects treated with either drug contained a factor which inhibited the adherence of normal granulocytes. The factor is heat stable, nondialyzable and not present in serum; it produces a linear dose response in normal cells. When mixed with the adherence-increasing factor found in inflammatory diseases, it neutralizes the augmenting effect and normal granulocyte adherence results.
      The effect of anti-inflammatory therapy on inflammatory disease was studied in aspirin-treated patients with rheumatoid arthritis. Their granulocyte adherence fell into two categories based on the clinical control of their disease: patients in good control had only slightly increased granulocyte adherence, but those in poor control had an average adherence more than twice normal. Mean blood aspirin levels were equivalent for the two groups (Math Eq for the well controlled and Math Eq for those poorly controlled). Thus, clinical response to anti-inflammatory therapy correlates well with granulocyte adherence, not with aspirin levels. The potential pathogenetic role of adherence-modifying factors in inflammatory diseases remains to be determined.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Garvin JE
        Factors affecting the adhesiveness of human leukocytes and platelets in vitro.
        J Exp Med. 1961; 114: 51
        • Marchesi VT
        • Florey HV
        Electron micrographic observations on the emigration of leukocytes.
        Q J Exp Physiol. 1960; 45: 343
        • MacGregor RR
        • Spagnuolo PJ
        • Lentnek AL
        Inhibition of granulocyte adherence by ethanol, prednisone, and aspirin, measured with a new assay system.
        N Engl J Med. 1974; 291: 642
        • Lentnek AL
        • Schreiber AD
        • MacGregor RR
        The induction of augmented granulocyte adherence by inflammation.
        J Clin Invest. 1976; 57: 1098
        • Weiner M
        • Piliero SJ
        Nonsteroid anti-inflammatory agents.
        Ann Rev Pharmacol. 1970; 10: 171
        • Allison A
        The role of lysosomes in the action of drugs and hormones.
        Adv Chemother. 1968; 3: 253
        • Weissman G
        Campbell PN Interaction of Drugs and Subcellular Components in Animal Cells. Churchill, London1968: 203
        • Vane JR
        Prostaglandins and the aspirin-like drugs.
        Hosp Practice. 1972; 7: 61
        • Willis AL
        • Davidson P
        • Smith JB
        • et al.
        Pharriss BB Ramwell PW Prostaglandins in Cellular Biology and the Inflammatory Process. Plenum, New York1972: 227
        • Ward PA
        Chemotaxis of polymorphonuclear leukocytes.
        Biochem Pharmacol. 1968; 17 (suppl): 99
        • Caner JEZ
        Colchicine inhibition of chemotaxis.
        Arthritis Rheum. 1965; 8: 757
        • Lehrer RI
        Effects of colchicine and chloramphenicol on the oxidative metabolism and phagocytic activity of human neutrophils.
        J Infect Dis. 1973; 127: 40
        • Malawista SE
        • Bensch KG
        Human polymorphonuclear leukocytes: demonstration of microtubules and effect of colchicine.
        Science. 1967; 156: 521
        • Paulus HE
        • Whitehouse MW
        Nonsteroid anti-inflammatory agents.
        Ann Rev Pharmacol. 1973; 13: 107
        • Mills JA
        Nonsteroidal anti-inflammatory drugs.
        N Engl J Med. 1974; 290: 781
        • Mills JA
        Nonsteroidal anti-inflammatory drugs.
        N Engl J Med. 1974; 290: 1002
        • Van Arman CG
        • Nuss GW
        Interactions of aspirin, indomethacin, and other drugs in adjuvant-induced arthritis in the rat.
        J Pharmacol Exp Ther. 1973; 187: 400
        • Hampton JR
        • Harrison MJG
        • Honour AJ
        • et al.
        Platelet behavior and drugs used in cardiovascular disease.
        Cardiovasc Res. 1967; 1: 101
        • Penny R
        • Galton DAG
        • Scott JT
        • et al.
        Studies on neutrophil function. I. Physiological and pharmacological aspects.
        Br J Haematol. 1966; 12: 623
        • Banks DC
        • Mitchell JR
        Leukocytes and thrombosis. II. Relationship between leukocyte behaviour and divalent cations, sulphydryl groups, red cells and adenosine diphosphate.
        Thromb Diath Haemorrh. 1973; 30: 47
        • Bryant RE
        • Sutcliffe MC
        The effect of 3′,5′-adenosine monophosphate on granulocyte adhesion.
        J Clin Invest. 1974; 54: 1241
        • Lichtman MA
        • Weed RI
        Alteration of the cell periphery during granulocyte maturation: relationship to cell function.
        Blood. 1972; 39: 301
        • Lichtman MA
        • Weed RI
        Peripheral cytoplasmic characteristics of leukocytes in monocytic leukemia: relationship to clinical manifestations.
        Blood. 1973; 40: 52
        • Lichtman MA
        Rheology of leukocytes, leukocyte suspensions, and blood in leukemia.
        J Clin Invest. 1973; 52: 350
        • Brandt L
        Adhesiveness to glass and phagocytic activity of neutrophilic leukocytes in myeloproliferative diseases.
        Scand J Haematol. 1965; 2: 126
        • Athens JW
        • Raab SO
        • Haab OP
        • et al.
        Blood granulocyte kinetics in chronic myelocytic leukemia.
        J Clin Invest. 1965; 44: 765
        • Duvall CP
        • Perry S
        The use of 51-chromium in the study of leukocyte kinetics in chronic myelocytic leukemia.
        J Lab Clin Med. 1968; 71: 614
        • Bishop CR
        • Athens JW
        • Boggs DR
        • et al.
        Leukokinetic studies. XIII. A non-steady-state kinetic evaluation of the mechanism of cortisone-induced granulocytosis.
        J Clin Invest. 1968; 47: 249